Cytomegalovirus Thrombophlebitis After Successful DHPG Therapy

  1. POWERS PETERSON, M.D.; and
  2. CELINE M. STAHL-BAYLISS, M.D.
  1. Cornell University Medical College;
    New York, NY 10021
  2. Memorial Sloan Kettering Cancer Center;
    New York, NY 10021

    Excerpt

    To the editor: Cytomegalovirus is a frequent cause of opportunistic infections in patients with the acquired immunodeficiency syndrome (AIDS) (1). 9-[1,3-dihydroxy-2-propoxy)methyl]guanine (DHPG) is a new, potent, and broadly active antiherpetic agent structurally similar to acyclovir. It was administered intravenously for 2 weeks to a male homosexual patient with persistent cytomegalovirus viremia. He was free of cytomegalovirus infection for 1 year and then developed a unique, previously unreported complication, cytomegalovirus thrombophlebitis.

    A 34-year-old white homosexual man was diagnosed with AIDS in November 1983, when Kaposi sarcoma was histologically confirmed. He remained well until November 1984, when he developed low-grade fevers, diffuse

    This 100-word excerpt has been provided in the absence of an abstract.

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement